(By Julio Ochoa, WUSF for Kaiser Health News)
When a hepatitis C treatment called Harvoni was released in 2014, Dr. Ronald Cirillo knew it was a big deal.
“It’s the reason that dragged me out of retirement!” he said. Continue reading article here…
This story was produced with the USC Center For Health Journalism’s National Fellowship and Kaiser Health News.
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.